Anke Verlinden
Impact in
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
- Oncology 9
- Neutropenia and Cancer Infections 5
- CAR-T cell therapy research 2
-
- Hematopoietic Stem Cell Transplantation 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Zwi Berneman (9 shared papers)Wilfried Schroyens (7 shared papers)Alain Gadisseur (8 shared papers)Herman Goossens (4 shared papers)Małgorzata Mikulska (1 shared paper)Nina Knelange (1 shared paper)Jan Styczyński (1 shared paper)Diana Averbuch (1 shared paper)
- Journals
- Blood (2 papers)British Journal of Cancer (1 paper)Frontiers in Immunology (1 paper)Leukemia Research (1 paper)Journal of Clinical Apheresis (1 paper)
- Partner nations
- BelgiumNetherlandsAustria
In The Last Decade
Anke Verlinden
19 papers receiving 212 citations
Peers
Comparison fields: 5 of 44
- Clinical Biochemistry 62
- Applied Microbiology and Biotechnology 11
- Hematology 54
- Oncology 108
- Molecular Medicine 17
Countries citing papers authored by Anke Verlinden
This map shows the geographic impact of Anke Verlinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Verlinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Verlinden more than expected).
Fields of papers citing papers by Anke Verlinden
This network shows the impact of papers produced by Anke Verlinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Verlinden. The network helps show where Anke Verlinden may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Verlinden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 40 | |
| 2 | 2021 | 29 | |
| 3 | 2014 | 23 | |
| 4 | 2013 | 18 | |
| 5 | 2020 | 15 | |
| 6 | 2021 | 10 | |
| 7 | 2019 | 9 | |
| 8 | 2017 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 8 | |
| 12 | 2016 | 8 | |
| 13 | 2017 | 7 | |
| 14 | 2016 | 6 | |
| 15 | 2017 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2017 | 1 | |
| 20 | A case series of 3 patients with acute colonic pseudo-obstruction after vincristine administration. | 2020 | 0 |
About Anke Verlinden
Anke Verlinden is a scholar working on Oncology, Hematology, Immunology, Clinical Biochemistry and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 212 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (5 papers), Neutropenia and Cancer Infections (5 papers), Mast cells and histamine (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Urticaria and Related Conditions (2 papers), Acute Myeloid Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Clinical Biochemistry (62 citations), Applied Microbiology and Biotechnology (11 citations), Hematology (54 citations), Oncology (108 citations) and Molecular Medicine (17 citations). Anke Verlinden has collaborated with scholars based in Belgium, Netherlands and Austria. Frequent co-authors include Zwi Berneman, Wilfried Schroyens, Alain Gadisseur, Herman Goossens, Małgorzata Mikulska, Nina Knelange, Jan Styczyński, Diana Averbuch, Hilde Jansens and Ann Van de Velde. Their work appears in journals such as Blood, British Journal of Cancer, Frontiers in Immunology, Leukemia Research and Journal of Clinical Apheresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.